Luna Van Den Brink

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

Journal: European urology open science
Published: June 17, 2026

Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials.

Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials.

Journal: European urology open science
Published: December 05, 2025

A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS).

A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS).

Journal: European urology focus
Published: October 31, 2025

The use of computed tomography during follow-up after ablation of cT1 renal cell carcinoma: evidence for overuse.

The use of computed tomography during follow-up after ablation of cT1 renal cell carcinoma: evidence for overuse.

Journal: European radiology
Published: October 03, 2025

A Closer Look at Radiation Exposure During Percutaneous Cryoablation for T1 Renal Tumors.

A Closer Look at Radiation Exposure During Percutaneous Cryoablation for T1 Renal Tumors.

Journal: Cancers
Published: May 06, 2025

Challenges in Follow-up After Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma: Insights from a Delphi Consensus.

Challenges in Follow-up After Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma: Insights from a Delphi Consensus.

Journal: European urology oncology
Published: March 30, 2025

A National Study of the Rate of Benign Pathology After Partial Nephrectomy for T1 Renal Cell Carcinoma: Should We Be Satisfied?

A National Study of the Rate of Benign Pathology After Partial Nephrectomy for T1 Renal Cell Carcinoma: Should We Be Satisfied?

Journal: Cancers
Published: September 02, 2024

Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review.

Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review.

Journal: European urology oncology
Published: August 12, 2024

Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?

Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?

Journal: European urology open science
Published: July 13, 2023
Showing 1-9 of 9

Last Updated: 09/26/2026